Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zheng Su

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Contemporary Clinical Trials|March 9, 2011
Balancing multiple baseline characteristics in randomized clinical trialsZheng Su
Contemporary Clinical Trials Communications|June 4, 2020
Different interpretations of the CheckMate-227 trial in non-small-cell lung cancerZheng Su
Contemporary Clinical Trials|August 18, 2010
Assessing the success probability of a Phase III clinical trial based on Phase II dataZheng Su
Contemporary Clinical Trials Communications|June 16, 2020
The critical role of futility analysis in the pursuit of effective treatments for COVID-19Zheng Su
Clinical Drug Investigation|April 9, 2010
An adaptive design for phase II non-oncology dose selection clinical trialsZheng Su
Contemporary Clinical Trials|November 3, 2009
A two-stage algorithm for designing phase I cancer clinical trials for two new molecular entitiesZheng Su
JAMA Dermatology|August 10, 2017
The Statistical Significance of the Efficacy Results in a Randomized Clinical TrialZheng Su
Pharmaceutical Statistics|July 31, 2013
A hybrid approach to achieving both marginal and conditional balances for stratification variables in sequential clinical trialsYunzhi Lin, Zheng Su
Contemporary Clinical Trials Communications|July 20, 2018
Is it time for the weighted log-rank test to play a more important role in confirmatory trials?Zheng Su, Ming Zhu
Computer Methods and Programs in Biomedicine|May 22, 2012
Quantifying the exact allocation ratios in randomized clinical trials with biased coin randomizationYunzhi Lin, Zheng Su
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Contemporary Clinical Trials|March 9, 2011
Balancing multiple baseline characteristics in randomized clinical trialsZheng Su
Contemporary Clinical Trials Communications|June 4, 2020
Different interpretations of the CheckMate-227 trial in non-small-cell lung cancerZheng Su
Contemporary Clinical Trials|August 18, 2010
Assessing the success probability of a Phase III clinical trial based on Phase II dataZheng Su
Contemporary Clinical Trials Communications|June 16, 2020
The critical role of futility analysis in the pursuit of effective treatments for COVID-19Zheng Su
Clinical Drug Investigation|April 9, 2010
An adaptive design for phase II non-oncology dose selection clinical trialsZheng Su
Contemporary Clinical Trials|November 3, 2009
A two-stage algorithm for designing phase I cancer clinical trials for two new molecular entitiesZheng Su
JAMA Dermatology|August 10, 2017
The Statistical Significance of the Efficacy Results in a Randomized Clinical TrialZheng Su
Pharmaceutical Statistics|July 31, 2013
A hybrid approach to achieving both marginal and conditional balances for stratification variables in sequential clinical trialsYunzhi Lin, Zheng Su
Contemporary Clinical Trials Communications|July 20, 2018
Is it time for the weighted log-rank test to play a more important role in confirmatory trials?Zheng Su, Ming Zhu
Computer Methods and Programs in Biomedicine|May 22, 2012
Quantifying the exact allocation ratios in randomized clinical trials with biased coin randomizationYunzhi Lin, Zheng Su
Pageof 25